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I will focus my discussion on three areas:
• twenty-first century biology,
• the enormous challenges that are facing us, and
• new models for partnerships.
TWENTY-FIRST CENTURY BIOLOGY
Isn’t twenty-first century biology the same as twentieth century biology?
More␣ than 10 years ago, Alan Bromley, Science Advisor to the elder Bush, made
this statement: “If this century is the age of physics”—and he’s a physicist—
“the twenty-first century will be the age of biology.” You have probably heard
that from many people since. President Clinton talked about the twenty-first
century being the age of biology. Al Gore thought he invented it. But when
Bromley made the statement more than 10 years ago, we hadn’t seen the
sequencing of the human genome. Sequencing the Arabidopsis genome was
just␣ something that people imagined might be possible. Fantastic things
happened during the last decade of the twentieth century, and the Arabidopsis
genome is a␣ particular achievement because it is the first eukaryote to be fully
sequenced. I mean completely, because the human genome is still in rough draft
and is not scheduled to be finished until 2003.
Twenty-first century biology is very different from the biology of even a few
years ago. It is multi-disciplinary. Teams of scientists are working together and
will continue to work together. Physicists, mathematicians, computer scientists,
and social scientists: all are focusing on the major questions in biology that will
be solved, I think, in this century.
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Twenty-first century biology is also multi-dimensional. For the first 50 years
of the biological revolution, i.e. since the elucidation of the structure of DNA
by␣ Watson and Crick, biology was mainly reductionist, whereas with the new
technologies and new disciplines we will be able to put all of the pieces
together and address questions from the atomic level through the ecosystem
level even to the planetary level.
It is also information-driven. Enormous quantities of data are being produced
and it is commonplace for scientists to “mine” databases like Genbank. New
hypotheses are being derived from sequence data—a capability that was
unimaginable a few years ago.
And, it is education-oriented because we need a new kind of scientist to
work␣ on these problems—one who is comfortable in a multi-disciplinary team
setting, and that is different from the biology of several years ago.
And twenty-first century biology engages people internationally. Geographic
boundaries no longer inhibit scientists. Because of the Internet we have what
Jack Marburger, President Bush’s Science Advisor, called the power of a “global
intelligence” to draw upon. Sometimes people find it easier to exchange ideas
and data across the globe than to walk down the hall and talk with a colleague.
SIX MAJOR CHALLENGES
Boxology Major challenges are associated with advancing twenty-first century
biology, which really isn’t biology, it’s twenty-first century science. I see six
major challenges, the biggest of which is to overcome twentieth-century
barriers. A colleague of mine calls this “boxology” because we all work in
boxes; we have to get outside of these boxes and think about the larger picture.
These boxes exist everywhere. They certainly exist in my agency, the National
Science Foundation (NSF), in which we have directorates, the Mathematics
and␣ Physical Sciences Directorate, the Biology Directorate, etc. Do we talk
across those boundaries? Yes we do, but it’s a huge challenge because of
differing cultures. You see this in universities. Certainly departmental barriers
exist that work against interdisciplinary research. Think about tenure decisions.
Tom Czeck talked to the National Science Board a week or so ago and said that
he was appalled recently at a committee meeting in which a faculty member
was being considered for tenure, and the question was asked, “How many times
has this person’s name appeared first on a paper?” Even though the person had
published lots of papers, the name had not appeared first on many of them. Yet
when you look at journals today, especially with these multidisciplinary
projects, like the Arabidopsis genome project or the human genome project, you
will see long lists of names. What happens to the person whose name is in the
middle? In some journals a statement is made that all the authors contributed
equally. What do tenure committees do with that kind of information? It is an
academic barrier that has to be overcome in some way.
Federal agency barriers exist not just at NSF. The Office of Management and
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Budget, where the budgets of the agencies are determined, exists in compart-
ments because the budget examiners focus on each agency separately. They
hardly ever coordinate across agencies. Only with cross-cutting efforts like the
global climate change project do they bring agency representatives together to
talk about coordinating budgets.
Broadening Participation A second major challenge is in broadening participa-
tion. It is essential that we tap the diversity in human resources in the United
States. It is a national scandal that we have not been able to increase the
participation of underrepresented minorities in science. But it is more than
underrepresented minorities. More and more students are opting out of
science—a recent report showed that 50% of undergraduates who major in
science drop out within the first couple of years. The major cause is not poor
grades but that courses aren’t interesting—the curriculum fails to engage the
student largely because of lack of faculty interest.
To broaden participation we must include diverse institutions, including
community colleges where many minority students get their start. Some 46%
of␣ underrepresented minorities attend community colleges, so we at the NSF
are putting a lot of emphasis on including all colleges and the tribal colleges.
It␣ is a major challenge.
Reshaping Education A third challenge relates to reshaping the education of
scientists and engineers to broaden the horizons of students who are interested
in majoring in science and engineering. Some of the programs that we support
at NSF, like the IGERT Traineeship Program, are exciting because students and
faculty work in multidisciplinary teams. We also think that postdocs need to
have a number of options. They should have the opportunity to teach, therefore
we are changing our postdoctoral programs at NSF to allow a semester or a year
to gain teaching experience. There should be possibilities for graduate students
and postdocs to have internships in industry, which we have not allowed until
now. And finally, all of them need international experience, which is essential
for the future.
Public Perceptions My fourth major challenge is public understanding of science.
A recent survey indicated broad popular acceptance internationally that solar
energy and computers will improve our lives. As for genetic engineering,
however, a sizeable number of people expressed the conviction that it will
make␣ things worse, similar to attitudes on nuclear power. This is something
that requires much thought, and foods for health should go a long way to
improving public perceptions of agricultural biotechnology.
Infrastructure The next major challenge is infrastructure and research facilities.
Costs of maintaining cyber-infrastructure—instrumentation, security, etc.—are
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going to skyrocket for universities. In 1998, research-one universities issued a
report in which the cost of maintaining facilities, not including upgrading with
the new technology, was estimated at over $11 billion. Clearly, the NSF cannot
address this issue alone. In fact, the whole federal government will have trouble
meeting this challenge.
Funding My final major challenge is funding—something that I know a lot
about. In an NSF publication, Science and Engineering Indicators, published in
May 2002, it was shown that the federal government supplied 66% of the funds
for R&D in 1960, whereas in 2000 industry supplied 72% and the federal
government only 28%. But, the 72% supplied by industry in 2000 was mainly
the “D” part of R&D—development of products. Only 5% of that 72% was
invested in fundamental research and the 28% provided by the federal
government was almost entirely for fundamental research and some applied
research. In short, industry will not replace the federal government’s support
for␣ fundamental research.
From 1967 to 2000, the United States Department of Agriculture (USDA) and
NSF grant funds were pretty flat in constant dollars. In contrast, federal funding
for Health and Human Services, which goes mostly to the National Institutes of
Health (NIH), has grown and is still growing, and will have doubled by 2003 at
over $27 billion. When I say that NSF needs a big increase, people sometimes
say, “Take it out of the Farm Bill.” However, we don’t want to take money
away␣ from any other agency. The NIH can use their increased funding very
profitably—there is no suggestion that we want to transfer money from NIH
to␣ any other agency. We need increased overall investment in research by the
federal government. Less than $350 million—not billion—were invested by the
government in competitive grants in plant biology in 2001. Clearly we have a
long way to go to reach adequate funding for twenty-first century biology.
NEW PARTNERSHIPS
How are we going to meet these challenges? We need new kinds of partners.
We␣ need effective partnerships involving private and public sectors. State
governments should also be involved and we need international partners.
In 1997, it was decided that we needed a long-term plan for plant genomics,
which was clearly a promising area. Under the leadership of Ron Phillips, an
interagency working group was established with a 5-year plan. The first thing
that we recommended was to complete the sequencing of Arabidopsis, which
has happened. We will hold a stakeholders’ workshop at the National Academy
on June 6 and 7, 2002, to plan the next 5 years.
The interagency national plant-genome initiative involves the NSF, the
Department of Energy (DOE), the NIH, and the USDA. As already stated, the
first priority was to sequence model-plant species, then we addressed the
research resources that would be needed, the databases, the kinds of technology
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development that needed to occur and, very importantly, data management
and␣ informatics. In fact we now insist on an informatics component in all of
the␣ projects in plant genomics now funded by NSF. So Arabidopsis-genome
sequencing was completed. The first completely sequenced plant genome—
found to have about 25,000 genes—was published in 2000 as a result of a
successful international partnership. Japan and the European Union were
involved, as was France in its own right through Genoscope. And, in the
United␣ States, NSF, USDA and DOE all supported the effort. One of my guiding
principles for international projects is that each country pays its own way
so␣ that it feels that it is a full partner, and this happened beautifully with
Arabidopsis—there were no problems. But, as I have said before, the reason
for␣ such great cooperation was probably that there was no money to be made.
Next we said that rice needed to be sequenced, because the genes of rice are
very similar to those in all of the grasses. Corn has a rather larger genome,
about the size of the human genome. We are receiving suggestions from the
corn community that it should be sequenced next, and then wheat.
The international rice genome project was another interesting partnership as
a new model of international collaboration. The members of that team are from
Korea, China, Taiwan, Thailand, India, the United Kingdom, France, and Brazil.
Japan is the lead nation, but China is catching up fast. China has sequenced
Oryza indica, whereas Japan and the other partners are sequencing O. japonica.
It is noteworthy that Monsanto provided data that was useful in completing
the␣ rice genome project. The data are being deposited in Genbank and will
be␣ publicly available. Discussions are going on now with Syngenta. I would
like␣ to think that companies will cooperate with the federal government and
private and public sources to produce the kind of model that will work for us
in␣ the future.
We are coordinating well on a couple of other projects. In the microbe
project we are doing everything we can to build the infrastructure, to connect
the dots, to learn as much as we can. This interagency working group involves
the CIA, FBI, Department of Defense, the Food and Drug Administration
(FDA), and NASA, etc. Our goal is to build the necessary infrastructure to learn
as much as we can about microbes, 99% of which have received little, if any,
study. Only a few that are pathogenic to humans have been thoroughly
studied—even then we have learned over the past few months how much
we␣ don’t know about anthrax.
Recently the National Academy held a workshop on domestic-animal
genomics, the result of which is an inter-agency working group that is chaired
by Joe Jen the Undersecretary for Research, Education and Economics at the
USDA. They are just getting started, discussing what kinds of sequencing need
to be done, etc., related to animal genomics.
The 2010 Project is another that involves international collaboration to
determine the function of all of the genes in Arabidopsis. It began last year and
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we hope it will be completed by 2010. All of the 2010 Project reports are
available on the Internet. Another international collaborative activity is the
USEC task force on biotechnology research, which was established in 1990 as
a␣ forum for discussion of new ideas. A Blue Sky Workshop—predicting what
biotechnology would look like 20 to 25 years from now—was in session on
September 11, 2001, in Washington, DC, and was rescheduled for June 2003
in␣ Brussels.
In closing, I will reiterate that we need new kinds of partnerships for twenty-
first century biology. Now only scratching the surface, we need involvement
of␣ the public sector, the states and local government as well as the federal
government, because we cannot do it alone.1
1The Q&A session with Dr. Clutter is on p. 185.
